Oncology Biosimilars Market Report

Global and Europe Oncology Biosimilars Market Professional Survey Report 2019

  • POSTDATE：Jun 20, 2020
  • PAGES：210
  • REPORT CODE：GMM569154
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Oncology Biosimilars market was valued at XX.0 million US$ in 2018, with the CAGR of 3.5%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Oncology Biosimilars market. Describe product range of Oncology Biosimilars, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Oncology Biosimilars market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Oncology Biosimilars market.

     

    By Player

    • STADA Arzneimittel AG

    • Sandoz International GmbH

    • Teva Pharmaceutical Industries Ltd

    • BIOCAD

    • Biocon

    By Type

    • G-CSF

    • Hematopoietic Agents

    • Monoclonal Antibodies

    By End-User

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Pharmacies

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilars Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

      • 1.3.2 Global Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

      • 1.3.3 Global Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.2 Global Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.3 Global Oncology Biosimilars Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oncology Biosimilars Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Biosimilars by Major Types

      • 3.4.1 Oncology Biosimilars Market Size and Growth Rate of G-CSF

      • 3.4.2 Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents

      • 3.4.3 Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies

    4 Segmentation of Oncology Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Biosimilars for Retail Pharmacies

      • 4.4.2 Market Size and Growth Rate of Oncology Biosimilars for Hospital Pharmacies

      • 4.4.3 Market Size and Growth Rate of Oncology Biosimilars for Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Global Oncology Biosimilars Production Analysis by Top Regions

    • 5.2 Global Oncology Biosimilars Consumption Analysis by Top Regions

    • 5.3 Global Oncology Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Oncology Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oncology Biosimilars Market among Top Countries

    • 6.1 Top 5 Export Countries in Oncology Biosimilars Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oncology Biosimilars Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncology Biosimilars Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oncology Biosimilars Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Oncology Biosimilars Landscape Analysis

    • 7.1 North America Oncology Biosimilars Landscape Analysis by Top Countries

      • 7.1.1 United States Oncology Biosimilars Market Volume and Growth Rate

      • 7.1.2 Canada Oncology Biosimilars Market Volume and Growth Rate

      • 7.1.3 Mexico Oncology Biosimilars Market Volume and Growth Rate

    8. Europe Oncology Biosimilars Landscape Analysis

    • 8.1 Europe Oncology Biosimilars Landscape Analysis by Major Types

    • 8.2 Europe Oncology Biosimilars Landscape Analysis by Major End-Users

    • 8.3 Europe Oncology Biosimilars Landscape Analysis by Top Countries

      • 8.3.1 Germany Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.2 UK Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.3 France Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.4 Italy Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.5 Spain Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.6 Belgium Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.7 Poland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.8 Russia Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.9 Turkey Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.10 Netherlands Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.11 Portugal Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.12 Denmark Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.13 Finland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.14 Iceland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.15 Norway Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.16 Sweden Oncology Biosimilars Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Oncology Biosimilars Landscape Analysis

    • 9.1 Asia Pacific Oncology Biosimilars Landscape Analysis by Top Countries

      • 9.1.1 China Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.2 Japan Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.4 India Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.5 ASEAN Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.6 South Korea Oncology Biosimilars Market Volume and Growth Rate

    10 LAMEA Oncology Biosimilars Landscape Analysis

    • 10.1 LAMEA Oncology Biosimilars Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.2 Brazil Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.3 North Africa Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.4 South Africa Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.5 Argentina Oncology Biosimilars Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 STADA Arzneimittel AG

      • 11.1.1 STADA Arzneimittel AG Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sandoz International GmbH

      • 11.2.1 Sandoz International GmbH Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Teva Pharmaceutical Industries Ltd

      • 11.3.1 Teva Pharmaceutical Industries Ltd Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 BIOCAD

      • 11.4.1 BIOCAD Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Biocon

      • 11.5.1 Biocon Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 78 Figures and 169 Tables)

    • Figure Product Picture

    • Figure Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

    • Figure Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

    • Figure Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • Figure Global Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Global Oncology Biosimilars Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure North America Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure United States Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure China Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure India Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of G-CSF

    • Figure Market Size and Growth Rate of Hematopoietic Agents

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Global Oncology Biosimilars Production by Major Regions

    • Table Global Oncology Biosimilars Production Share by Major Regions

    • Table Global Oncology Biosimilars Consumption by Major Regions

    • Table Global Oncology Biosimilars Consumption Share by Major Regions

    • Table North America Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Europe Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table LAMEA Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table North America Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2014

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2018

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2026

    • Figure United States Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure France Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure China Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure India Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of STADA Arzneimittel AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of STADA Arzneimittel AG

    • Figure Sales and Growth Rate Analysis of STADA Arzneimittel AG

    • Figure Revenue and Market Share Analysis of STADA Arzneimittel AG

    • Table Product and Service Introduction of STADA Arzneimittel AG

    • Table Company Profile and Development Status of Sandoz International GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH

    • Figure Sales and Growth Rate Analysis of Sandoz International GmbH

    • Figure Revenue and Market Share Analysis of Sandoz International GmbH

    • Table Product and Service Introduction of Sandoz International GmbH

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of BIOCAD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD

    • Figure Sales and Growth Rate Analysis of BIOCAD

    • Figure Revenue and Market Share Analysis of BIOCAD

    • Table Product and Service Introduction of BIOCAD

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US